Related Experiment Video
Updated: Jul 3, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma
Richard J Flavin1, Paul C Smyth, Alexandros Laios
1Department of Histopathology, Trinity College Dublin, Dublin, Ireland. flavinr@tcd.ie
Abstract:
MicroRNAs are a group of small non-coding RNAs approximately 22 nucleotides in length. Recent work has shown differential expression of mature microRNAs in human cancers. We characterized the alteration in expression of a select group of microRNAs in primary peritoneal carcinoma relative to matched cases of ovarian serous carcinoma. MicroRNA expression was analysed using semi-quantitative stem-loop RT-PCR on a set of 34 formalin-fixed paraffin-embedded samples. Protein expression of p53 and bcl-2 was quantified in the corresponding tissue microarray. We provide definitive evidence that there is downregulation of a select group of microRNAs in tumours meeting Gynaecological Oncology Group criteria for primary peritoneal carcinoma relative to ovarian serous carcinoma. Specifically, we show decreased p53 expression and downregulation of miR-195 and miR-497 from the microRNA cluster site at chromosome 17p13.1 in primary peritoneal carcinoma relative to ovarian serous carcinoma. miR-195 and miR-497 may have potential roles as tumour-suppressor genes in primary peritoneal tumourigenesis.
Insights
Primary peritoneal carcinoma shows reduced microRNA levels compared to ovarian cancer. Specifically, miR-195 and miR-497 downregulation suggests a tumor-suppressor role in primary peritoneal cancer development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs crucial in gene regulation.
- Aberrant miRNA expression is implicated in various human cancers.
- Differential miRNA expression patterns distinguish cancer subtypes.
Purpose of the Study:
- To investigate miRNA expression alterations in primary peritoneal carcinoma (PPC) compared to ovarian serous carcinoma (OSC).
- To identify specific miRNAs and their potential roles in PPC tumorigenesis.
- To correlate miRNA expression with protein markers like p53 and bcl-2.
Main Methods:
- Semi-quantitative stem-loop RT-PCR was used to analyze miRNA expression in 34 formalin-fixed paraffin-embedded samples.
- Tissue microarrays were employed for quantifying protein expression of p53 and bcl-2.
- Comparative analysis was performed between PPC and matched OSC cases.
Main Results:
- Downregulation of specific microRNAs was observed in PPC relative to OSC.
- miR-195 and miR-497, located at chromosome 17p13.1, were significantly downregulated in PPC.
- Decreased p53 protein expression was noted in PPC compared to OSC.
Conclusions:
- Primary peritoneal carcinoma exhibits distinct microRNA expression profiles compared to ovarian serous carcinoma.
- Downregulated miR-195 and miR-497 suggest a tumor-suppressor function in primary peritoneal cancer.
- These miRNAs represent potential diagnostic or therapeutic targets for primary peritoneal carcinoma.
Related Concept Videos
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
